|
Market Closed -
Euronext Paris
11:55:00 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 1.140 EUR | +0.53% |
|
-12.31% | -76.30% |
| 09-21 | MaaT Pharma Schedules Pre-IND Meeting with FDA and Advances MaaT034 Toward Clinical Development in Solid Tumors | CI |
| 09-18 | MaaT Pharma Says EU Regulator Maintains Negative Opinion on Xervyteg | MT |
Chart: Technical Analysis
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| MAAT | Real-time | |
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| 4RD | Delayed | |
|
Börse Stuttgart
| 4RD | Delayed | |
|
Boerse Muenchen
| 4RD | Real-time | |
|
CBOE
| Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 3.19 | 3.19 | 3.19 |
| Spread/Res. | -64.26% | -64.26% | -64.26% |
| Spread/Supp. | +5.56% | +5.56% | +0.53% |
| Support | 1.08 | 1.08 | 1.134 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MAAT Stock
- Charts MaaT Pharma
Select your edition
All financial news and data tailored to specific country editions
